Literature DB >> 2473583

[Experimental detection of the paraspecific effects of purified and inactivated poxviruses].

A Mayr, M Büttner, G Wolf, H Meyer, C Czerny.   

Abstract

The paraspecific effect of pox viruses i.e. stimulation of the nonspecific part of the complex immune system, was demonstrated in vitro and in vivo for 3 different types of virus (vaccinia virus, avipox virus, parapox virus). By means of purification, concentration and inactivation, it was possible to prove that the paraspecific effect is brought about by the pox virus particle per se. The effect is induced by certain epitopes in the complex structure of the virus and is independent of virus multiplication. Both purified pox viruses and inactivated, purified pox viruses stimulate NK cell activity, the CSA and the formation of interferon, and reach higher efficacy indices in a challenge test with baby mice using stomatitis vesicularis virus than non-purified and non-inactivated cell culture material. The degree of purity of the pox virus preparations was established using the electron microscope and monoclonal antibodies. The purified and concentrated pox virus preparations proved to be pyrogen-free; they were not toxic to baby mice in vivo. An endotoxin-induced effect could be ruled out. The broad paraspecific effect of pox viruses and their structural components lends itself to use as paramunity inducers in prophylaxis and therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473583

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  9 in total

1.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic.

Authors:  Julia L Rintoul; Chantal G Lemay; Lee-Hwa Tai; Marianne M Stanford; Theresa J Falls; Christiano T de Souza; Byram W Bridle; Manijeh Daneshmand; Pamela S Ohashi; Yonghong Wan; Brian D Lichty; Andrew A Mercer; Rebecca C Auer; Harold L Atkins; John C Bell
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

3.  Selective induction of apoptosis in antigen-presenting cells in mice by Parapoxvirus ovis.

Authors:  N Kruse; O Weber
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  A novel inhibitor of the NF-{kappa}B signaling pathway encoded by the parapoxvirus orf virus.

Authors:  D G Diel; G Delhon; S Luo; E F Flores; D L Rock
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

5.  Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.

Authors:  Ning Yang; Aitor Garcia; Cindy Meyer; Thomas Tuschl; Taha Merghoub; Jedd D Wolchok; Liang Deng
Journal:  NPJ Vaccines       Date:  2022-10-19       Impact factor: 9.399

6.  Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis.

Authors:  Sabine Siegemund; Andrea Hartl; Heiner von Buttlar; Franziska Dautel; Rüdiger Raue; Marina A Freudenberg; György Fejer; Mathias Büttner; Gabriele Köhler; Carsten J Kirschning; Tim Sparwasser; Gottfried Alber
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

7.  Invariant Valpha14 chain NKT cells promote Plasmodium berghei circumsporozoite protein-specific gamma interferon- and tumor necrosis factor alpha-producing CD8+ T cells in the liver after poxvirus vaccination of mice.

Authors:  Simone Korten; Richard J Anderson; Carolyn M Hannan; Eric G Sheu; Robert Sinden; Stephan Gadola; Masaru Taniguchi; Adrian V S Hill
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Modulation of macrophage functions by sheeppox virus provides clues to understand interaction of the virus with host immune system.

Authors:  Abdel-Aziz S Abu-El-Saad; Ahmed S Abdel-Moneim
Journal:  Virol J       Date:  2005-03-22       Impact factor: 4.099

Review 9.  Therapeutic immunomodulation using a virus--the potential of inactivated orf virus.

Authors:  O Weber; A A Mercer; A Friebe; P Knolle; H-D Volk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-22       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.